Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
about
shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapySurvivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells.Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer.Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells.Molecular alterations in key-regulator genes among patients with T4 breast carcinoma.Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3.Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma.Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice.The Chinese herb isolate isorhapontigenin induces apoptosis in human cancer cells by down-regulating overexpression of antiapoptotic protein XIAP.The transcription factor c-Jun protects against liver damage following activated β-Catenin signaling.Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection.Smac mimetic SM-164 potentiates APO2L/TRAIL- and doxorubicin-mediated anticancer activity in human hepatocellular carcinoma cellsEffects of ginsenoside Rh2 on growth and migration of pancreatic cancer cellsSimultaneous silencing of VEGF and KSP by siRNA cocktail inhibits proliferation and induces apoptosis of hepatocellular carcinoma Hep3B cells.Apoptotic cell signaling in cancer progression and therapyOxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome cmiR-296 regulation of a cell polarity-cell plasticity module controls tumor progression.Downregulation of Vascular Endothelial Growth Factor Enhances Chemosensitivity by Induction of Apoptosis in Hepatocellular Carcinoma Cells.Role of melanoma inhibitor of apoptosis (ML-IAP) protein, a member of the baculoviral IAP repeat (BIR) domain family, in the regulation of C-RAF kinase and cell migrationLocal injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrestFrom big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma.IAP proteins as targets for drug development in oncologyExpression and clinical significance of livin protein in hepatocellular carcinoma.XIAP expression is associated with pancreatic carcinoma outcome.Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells.Role of Bcl-2 family proteins and caspases in the regulation of apoptosis.Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.ARTS-based anticancer therapy: taking aim at cancer stem cells.IAPS and ubiquitylation.Apoptosis-modulating drugs for improved cancer therapy.The role and therapeutic implications of RING-finger E3 ubiquitin ligases in hepatocellular carcinoma.Non-coding RNAs in Mammary Gland Development and Disease.CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.The effects of Livin shRNA on the response to cisplatin in HepG2 cells.Expression of livin, survivin and caspase-3 in prostatic cancer and their clinical significanceYM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines.siRNA targeting Livin decreases tumor in a xenograft model for colon cancerClioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer.
P2860
Q26765364-08A58BF0-7669-401F-8326-278320ED33A7Q31109734-DF9C50B9-9DE3-43F8-A183-AFBDC16349A2Q33491820-B857D477-6303-41AA-91D2-7D180044DC83Q33624824-F33933E4-A7EF-4E0D-A0DA-BFF9604448DFQ33626354-9D2F754E-4056-4831-BBD6-06923B03EF8AQ33671525-2919FC36-3F7E-42F4-B3AE-027EF1A62869Q33841579-4B94B304-27F7-4174-B3C4-7B8D5D1EC10DQ33933676-C7E1B6D1-08AA-48EC-9106-2E4933E506EBQ34060255-9A8ADE11-DD91-46C7-9FD8-34A3F7DC1E91Q34117033-3B1D0469-C471-4E49-9F97-EF7498A287A3Q34294301-580FA4FC-0EA8-40E6-AA5E-A8F2476DC506Q34336646-6E442A5F-5005-4CA7-8B98-9BB1BAB850A1Q34494794-8F364386-787A-4A61-945E-CB554941CCA2Q34512395-E34FD03F-03A3-40FD-9AF4-41C8CA4A48EFQ34641361-035AB969-9E77-497C-9018-5DCB39993E76Q34900837-4A5E8823-D770-4F09-8119-A57B945065A5Q35088734-D7B6E331-1940-4E65-87FD-9B521F97F654Q35121860-A2C169C4-40EC-47EE-911E-3CF38A783D43Q35656084-4F930CB8-8F54-4722-922F-D8C04E65FF23Q35856029-7CCD250D-D479-41C6-9A5D-9B7346A67FE3Q36217262-FA6FC4AC-026C-4B08-8250-D8847819D1FFQ36305414-B2E175B0-DF51-439B-9C1F-721D8312FF5DQ36313998-CA93D2FE-A5B2-4B42-8C95-452EB46685D3Q37209606-2E75A94C-80D3-4CD8-828E-9821BB0BCF17Q37260289-B84EDADB-A7C5-46FD-BE9C-E12185D72D99Q37560722-8BCE40F9-10AD-412A-A9C0-CB2B3014252BQ37705988-EF472616-B5E0-4B4C-997E-CBD0C7C05A55Q37826384-5DF73F8A-8CC5-467F-9493-717F0A381B04Q37867584-258CD7A7-7285-49BC-A5A0-5A1A6477C576Q37944935-A92C3F20-D7A8-41C6-A361-81972A4D6FB2Q37987881-941B396B-5FAD-4A5C-9D24-9103E4778957Q38005914-E102BFF6-DF04-4E14-A2A5-DE9FE01F3427Q38178169-C0BC75EE-0F62-4488-8D28-7C3B42CF1C02Q38667231-ED17B4E3-222E-418B-A69B-B789E2BBBD8AQ38736933-03410219-50AA-4899-9BED-DDB8B583AF87Q38807287-2CE1F199-2D4A-43FB-AA3E-5518245DF415Q38914726-385EB333-C042-47A7-B3DD-E539F878AB70Q38932250-18EC2585-DCD0-46BA-84B7-9DB95F3E4FD1Q39531905-5013FEA8-0B54-431E-A6DB-6110A3660366Q39572385-1494C004-86D1-4B4F-B6D3-2B6713F0EB98
P2860
Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inhibitors of apoptosis protei ...... e in hepatocellular carcinoma.
@ast
Inhibitors of apoptosis protei ...... e in hepatocellular carcinoma.
@en
type
label
Inhibitors of apoptosis protei ...... e in hepatocellular carcinoma.
@ast
Inhibitors of apoptosis protei ...... e in hepatocellular carcinoma.
@en
prefLabel
Inhibitors of apoptosis protei ...... e in hepatocellular carcinoma.
@ast
Inhibitors of apoptosis protei ...... e in hepatocellular carcinoma.
@en
P2093
P2860
P50
P356
P1433
P1476
Inhibitors of apoptosis protei ...... ce in hepatocellular carcinoma
@en
P2093
Caterina Pellegrini
Claudia Augello
Guido Coggi
Luca Caruso
Marco Maggioni
Marco Montorsi
Matteo Donadon
P2860
P2888
P356
10.1186/1471-2407-9-125
P407
P577
2009-04-27T00:00:00Z
P5875
P6179
1036098300